BEVERLY, Mass. and TORONTO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading
world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART)
and developmental biology research markets, today announced that it will release its financial results for the three and
nine-months ended September 30, 2017 after the market closes Tuesday, November 21, 2017. The press release, with accompanying
financial information, will be posted on the Company’s website at www.hamiltonthorne.com and on www.sedar.com.
The Company will follow with a conference call Wednesday, November 22, 2017, at 11:00 a.m. EST to review highlights of its
quarterly results. All interested parties are welcome to join the conference call by dialing toll free 1-855-223-7309 in North
America, or 647-788-4929 from other locations, and requesting Conference ID 1669069. A recording of the call will be available on
Hamilton Thorne’s website shortly after the call.
About Hamilton Thorne Ltd. (www.hamiltonthorne.com)
Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost,
increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental
biology research markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed and Embryotech
Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of
fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and
other commercial and academic research establishments.
Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the
exchange), accepts responsibility for the adequacy or accuracy of this release.
For more information, please contact:
